Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma.

doi:10.1046/j.1524-4725.2000.99287.x

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] - 1 May 2000

Tope W D, Nowfar-Rad M, Kist D A

Abstract excerpt

BACKGROUND: Well-defined histopathologic criteria exist to distinguish actinic keratosis (AK) from superficial basal cell carcinoma (BCC). A similar morphology of downwardly budding dysplastic keratinocytes may occur in both entities, creating potential for errors in diagnosis. A marker that could reliably distinguish these two lesions would overcome this difficulty in diagnosis. OBJECTIVE: To investigate whether...

Topics

Antibodies, Monoclonal
Antigens, Surface
Biomarkers, Tumor
Carcinoma, Basal Cell
Carcinoma, Squamous Cell
Diagnosis, Differential
Humans
Immunohistochemistry
Phenotype
Precancerous Conditions
Predictive Value of Tests
Skin Neoplasms

Source

Open in PubMed

Identifiers

PMID: 10816226
DOI: 10.1046/j.1524-4725.2000.99287.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics